Cargando…
Corrigendum: Selective targeting of HDAC1/2 elicits anticancer effects through Gli1 acetylation in preclinical models of SHH Medulloblastoma
| Autores principales: | , , , , , , , , , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Nature Publishing Group
2017
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5399352/ https://www.ncbi.nlm.nih.gov/pubmed/28429760 http://dx.doi.org/10.1038/srep46645 |
| _version_ | 1783230625674690560 |
|---|---|
| author | Coni, Sonia Mancuso, Anna Barbara Di Magno, Laura Sdruscia, Giulia Manni, Simona Serrao, Silvia Maria Rotili, Dante Spiombi, Eleonora Bufalieri, Francesca Petroni, Marialaura Kusio-Kobialka, Monika De Smaele, Enrico Ferretti, Elisabetta Capalbo, Carlo Mai, Antonello Niewiadomski, Pawel Screpanti, Isabella Di Marcotullio, Lucia Canettieri, Gianluca |
| author_facet | Coni, Sonia Mancuso, Anna Barbara Di Magno, Laura Sdruscia, Giulia Manni, Simona Serrao, Silvia Maria Rotili, Dante Spiombi, Eleonora Bufalieri, Francesca Petroni, Marialaura Kusio-Kobialka, Monika De Smaele, Enrico Ferretti, Elisabetta Capalbo, Carlo Mai, Antonello Niewiadomski, Pawel Screpanti, Isabella Di Marcotullio, Lucia Canettieri, Gianluca |
| author_sort | Coni, Sonia |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-5399352 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2017 |
| publisher | Nature Publishing Group |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-53993522017-04-21 Corrigendum: Selective targeting of HDAC1/2 elicits anticancer effects through Gli1 acetylation in preclinical models of SHH Medulloblastoma Coni, Sonia Mancuso, Anna Barbara Di Magno, Laura Sdruscia, Giulia Manni, Simona Serrao, Silvia Maria Rotili, Dante Spiombi, Eleonora Bufalieri, Francesca Petroni, Marialaura Kusio-Kobialka, Monika De Smaele, Enrico Ferretti, Elisabetta Capalbo, Carlo Mai, Antonello Niewiadomski, Pawel Screpanti, Isabella Di Marcotullio, Lucia Canettieri, Gianluca Sci Rep Corrigenda Nature Publishing Group 2017-04-21 /pmc/articles/PMC5399352/ /pubmed/28429760 http://dx.doi.org/10.1038/srep46645 Text en Copyright © 2017, The Author(s) http://creativecommons.org/licenses/by/4.0/ This work is licensed under a Creative Commons Attribution 4.0 International License. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in the credit line; if the material is not included under the Creative Commons license, users will need to obtain permission from the license holder to reproduce the material. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/ |
| spellingShingle | Corrigenda Coni, Sonia Mancuso, Anna Barbara Di Magno, Laura Sdruscia, Giulia Manni, Simona Serrao, Silvia Maria Rotili, Dante Spiombi, Eleonora Bufalieri, Francesca Petroni, Marialaura Kusio-Kobialka, Monika De Smaele, Enrico Ferretti, Elisabetta Capalbo, Carlo Mai, Antonello Niewiadomski, Pawel Screpanti, Isabella Di Marcotullio, Lucia Canettieri, Gianluca Corrigendum: Selective targeting of HDAC1/2 elicits anticancer effects through Gli1 acetylation in preclinical models of SHH Medulloblastoma |
| title | Corrigendum: Selective targeting of HDAC1/2 elicits anticancer effects through Gli1 acetylation in preclinical models of SHH Medulloblastoma |
| title_full | Corrigendum: Selective targeting of HDAC1/2 elicits anticancer effects through Gli1 acetylation in preclinical models of SHH Medulloblastoma |
| title_fullStr | Corrigendum: Selective targeting of HDAC1/2 elicits anticancer effects through Gli1 acetylation in preclinical models of SHH Medulloblastoma |
| title_full_unstemmed | Corrigendum: Selective targeting of HDAC1/2 elicits anticancer effects through Gli1 acetylation in preclinical models of SHH Medulloblastoma |
| title_short | Corrigendum: Selective targeting of HDAC1/2 elicits anticancer effects through Gli1 acetylation in preclinical models of SHH Medulloblastoma |
| title_sort | corrigendum: selective targeting of hdac1/2 elicits anticancer effects through gli1 acetylation in preclinical models of shh medulloblastoma |
| topic | Corrigenda |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5399352/ https://www.ncbi.nlm.nih.gov/pubmed/28429760 http://dx.doi.org/10.1038/srep46645 |
| work_keys_str_mv | AT conisonia corrigendumselectivetargetingofhdac12elicitsanticancereffectsthroughgli1acetylationinpreclinicalmodelsofshhmedulloblastoma AT mancusoannabarbara corrigendumselectivetargetingofhdac12elicitsanticancereffectsthroughgli1acetylationinpreclinicalmodelsofshhmedulloblastoma AT dimagnolaura corrigendumselectivetargetingofhdac12elicitsanticancereffectsthroughgli1acetylationinpreclinicalmodelsofshhmedulloblastoma AT sdrusciagiulia corrigendumselectivetargetingofhdac12elicitsanticancereffectsthroughgli1acetylationinpreclinicalmodelsofshhmedulloblastoma AT mannisimona corrigendumselectivetargetingofhdac12elicitsanticancereffectsthroughgli1acetylationinpreclinicalmodelsofshhmedulloblastoma AT serraosilviamaria corrigendumselectivetargetingofhdac12elicitsanticancereffectsthroughgli1acetylationinpreclinicalmodelsofshhmedulloblastoma AT rotilidante corrigendumselectivetargetingofhdac12elicitsanticancereffectsthroughgli1acetylationinpreclinicalmodelsofshhmedulloblastoma AT spiombieleonora corrigendumselectivetargetingofhdac12elicitsanticancereffectsthroughgli1acetylationinpreclinicalmodelsofshhmedulloblastoma AT bufalierifrancesca corrigendumselectivetargetingofhdac12elicitsanticancereffectsthroughgli1acetylationinpreclinicalmodelsofshhmedulloblastoma AT petronimarialaura corrigendumselectivetargetingofhdac12elicitsanticancereffectsthroughgli1acetylationinpreclinicalmodelsofshhmedulloblastoma AT kusiokobialkamonika corrigendumselectivetargetingofhdac12elicitsanticancereffectsthroughgli1acetylationinpreclinicalmodelsofshhmedulloblastoma AT desmaeleenrico corrigendumselectivetargetingofhdac12elicitsanticancereffectsthroughgli1acetylationinpreclinicalmodelsofshhmedulloblastoma AT ferrettielisabetta corrigendumselectivetargetingofhdac12elicitsanticancereffectsthroughgli1acetylationinpreclinicalmodelsofshhmedulloblastoma AT capalbocarlo corrigendumselectivetargetingofhdac12elicitsanticancereffectsthroughgli1acetylationinpreclinicalmodelsofshhmedulloblastoma AT maiantonello corrigendumselectivetargetingofhdac12elicitsanticancereffectsthroughgli1acetylationinpreclinicalmodelsofshhmedulloblastoma AT niewiadomskipawel corrigendumselectivetargetingofhdac12elicitsanticancereffectsthroughgli1acetylationinpreclinicalmodelsofshhmedulloblastoma AT screpantiisabella corrigendumselectivetargetingofhdac12elicitsanticancereffectsthroughgli1acetylationinpreclinicalmodelsofshhmedulloblastoma AT dimarcotulliolucia corrigendumselectivetargetingofhdac12elicitsanticancereffectsthroughgli1acetylationinpreclinicalmodelsofshhmedulloblastoma AT canettierigianluca corrigendumselectivetargetingofhdac12elicitsanticancereffectsthroughgli1acetylationinpreclinicalmodelsofshhmedulloblastoma |